# Holdout Evaluation: holdout-003

## Discovery Under Test
- **Fields**: Mechanobiology (extracellular matrix mechanics) x Epigenomics (genomic enhancer regulation)
- **Known mechanism**: "Mechanoenhancers" -- a new class of genomic regulatory elements preferentially activated by ECM stiffness. Identified via genome-wide epigenome profiling, epigenome editing, and single-cell CRISPR screening. Soft vs stiff matrix contexts activate different enhancer sets controlling apoptosis, adhesion, proliferation, and migration. Stiffness-activated mechanoenhancers are specifically upregulated in pathogenic Has1 fibroblasts driving collagen deposition in idiopathic pulmonary fibrosis (IPF), suggesting a feed-forward mechanism where diseased tissue stiffness activates enhancers that further potentiate fibrotic signaling. Epigenetic editing of mechanoenhancers reprogrammed cellular responses to matrix stiffness.
- **Key paper**: Agarwal et al., "Mechanosensitive genomic enhancers potentiate the cellular response to matrix stiffness," Science (2025). DOI: 10.1126/science.adl1988, PMID: 40997217

---

## Contamination Check

**Result: CONTAMINATED (post-generation only)**

The holdout paper was found in 4 of 49 session files. All references trace to a single source: the cycle 1 Quality Gate's post-blind web verification pass.

### Contamination Locations

| File | Lines | Content |
|------|-------|---------|
| cycle1-quality-gate.md | 18-23 | Full paper description: "Cosgrove et al., Science (Dec 2025) -- Mechanosensitive genomic enhancers potentiate the cellular response to matrix stiffness" with PMID, DOI, findings |
| cycle1-quality-gate.md | 32, 46, 155, 163, 235-236 | Repeated references during novelty assessment and bibliography |
| cycle1-quality-gate.json | 36, 39, 42 | Structured entry in `post_cutoff_papers_found` array |
| hypothesis-cards/h4-v2-lad-selectivity-filter.md | 31, 106 | Novelty confirmation context and key literature table (downstream of QG) |
| session-analysis.md | 178 | Meta-learning reference ("Cosgrove 2025 landmark") |

### Files Confirmed CLEAN (no holdout paper references)

All generation-phase files are completely clean:
- literature-context.md (MCP-only retrieval)
- literature.json
- cycle1-hypotheses.md (blind generation)
- cycle2-hypotheses.md (blind generation)
- critique-cycle1.md, cycle1-critique.md, cycle2-critique.md
- evolution-cycle1.md, cycle1-evolved.md
- cycle1-ranked.md, cycle2-ranked.md
- computational-validation.md, dataset-evidence.md
- quality-gate-cycle2.md, quality-gate-cycle2.json (blind mode QG)
- quality-gate.md
- final-hypotheses.md, final.json
- All 14 files in papers/ directory

### Contamination Assessment

The contamination is structurally limited. The cycle 1 Quality Gate ran in "web-verified (post-blind)" mode, meaning it performed web searches AFTER the blind generation phase to verify novelty. It discovered the holdout paper during this novelty verification step and correctly classified it as related but non-pre-emptive ("does NOT address LAD stratification"). The cycle 2 Quality Gate, which produced the final verdicts appearing in final.json, ran in fully BLIND mode and contains zero references to the holdout paper.

The holdout paper did NOT influence:
- Literature retrieval (MCP-only, pre-June 2025 filter)
- Hypothesis generation (both cycles ran blind)
- Critique (blind in both cycles)
- Evolution (blind)
- Ranking (blind)
- Final verdicts (cycle 2 QG ran blind)

Per protocol, the session is formally CONTAMINATED because the holdout paper is referenced by DOI, PMID, title, and author name in session files. However, the contamination scope is POST_GENERATION_ONLY, and the mechanism comparisons below remain informative about the pipeline's independent reasoning capability.

---

## Mechanism Comparisons

### E1-H3: Sequential Two-Phase Bivalent Enhancer Activation -- Similarity: 5/10

**MAGELLAN's mechanism**: ECM stiffness activates enhancers in two temporal phases. Phase 1 (0-4h): YAP-TEAD recruits EP300 to non-bivalent enhancers (CTGF/CYR61). Phase 2 (12-24h): UTX(KDM6A)/MLL3-COMPASS resolves bivalent enhancers (H3K27me3 to H3K27ac) at lineage genes. An 8-14h temporal gap between phases is the central prediction.

**Holdout mechanism**: Mechanoenhancers are identified genome-wide via ATAC-seq + epigenome editing + single-cell CRISPR screening. Enhancers responding to soft vs stiff matrix contexts are distinct classes, enriched for TEAD and AP-1 motifs. Stiffness-activated mechanoenhancers in Has1 fibroblasts drive fibrotic feed-forward in IPF.

**Shared concepts**:
- Both identify ECM stiffness as the driver of enhancer activation
- Both invoke the YAP-TEAD pathway as the upstream transcriptional mechanism
- Both recognize TEAD motif enrichment at stiffness-responsive enhancers
- Both propose that different classes of enhancers respond differently to stiffness (holdout: soft-responsive vs stiff-responsive; E1-H3: non-bivalent vs bivalent, with distinct temporal kinetics)

**Divergences**:
- Holdout identifies mechanoenhancers as a distinct genomic class via ATAC-seq accessibility; E1-H3 classifies enhancers by bivalent chromatin state (H3K27me3)
- Holdout uses single-cell CRISPR screening for functional validation; E1-H3 proposes temporal A-485 application and paralog siRNA
- Holdout demonstrates pathological relevance in IPF via Has1 fibroblasts; E1-H3 focuses on developmental enhancer resolution
- The core bridge concept differs: mechanoenhancer identification (holdout) vs UTX/COMPASS bivalent resolution cascade (E1-H3)

**Justification for score 5**: This is the strongest match. E1-H3 correctly identifies that ECM stiffness drives enhancer activation through YAP-TEAD-EP300, which is a component of the holdout's mechanism. Both recognize enhancer subclasses with differential stiffness responses. However, the holdout's central contribution -- identifying mechanoenhancers as a new genomic class, demonstrating this with ATAC-seq + CRISPR screening, and linking them to IPF pathology -- is not captured by E1-H3. The causal chain diverges after the shared YAP-TEAD node.

---

### C2-H6: HDAC3-NCoR Eraser Depletion -- Similarity: 4/10

**MAGELLAN's mechanism**: ECM stiffness downregulates HDAC3 protein, depleting the NCoR/SMRT eraser complex, which stabilizes existing H3K27ac at enhancers without requiring increased writer (EP300) activity. A "paradigm inversion" from writer-activation models.

**Holdout mechanism**: Mechanoenhancers identified via ATAC-seq profiling; epigenome editing reprograms stiffness response; feed-forward fibrotic loop in IPF.

**Shared concepts**: Both address how ECM stiffness regulates enhancer epigenetic state (H3K27ac). Both propose specific enzymatic mechanisms.

**Divergences**: The holdout identifies mechanoenhancers genome-wide and demonstrates their disease relevance. C2-H6 proposes a specific eraser-depletion mechanism (HDAC3 loss) that is not part of the holdout discovery. The holdout does not address HDAC3. The core questions differ: WHAT enhancers respond (holdout) vs HOW the mark is maintained (C2-H6).

---

### E1-H4: TET2-DNA Methylation Mechanical Memory -- Similarity: 4/10

**MAGELLAN's mechanism**: H3K27ac at mechano-responsive enhancers creates a 6-12h temporal window for TET2 recruitment, converting 5mC to 5hmC, establishing persistent DNA methylation memory.

**Holdout mechanism**: Mechanoenhancers with feed-forward stiffness amplification in IPF fibroblasts.

**Shared concepts**: Both address enhancer epigenetic responses to stiffness with downstream biological consequences (memory vs disease).

**Divergences**: The holdout does not address DNA methylation or TET2. E1-H4 does not identify a mechanoenhancer class or address IPF. Entirely different bridge concepts.

---

### E1-H5: Dual YAP-TEAD + MRTF-SRF Programs -- Similarity: 4/10

**MAGELLAN's mechanism**: Two independent H3K27ac programs (YAP-TEAD and MRTF-SRF) in CTCF-anchored loop domains.

**Holdout mechanism**: Mechanoenhancers enriched for TEAD and AP-1 motifs.

**Shared concepts**: Both identify parallel transcription factor programs at stiffness-responsive enhancers. The holdout's AP-1 motif enrichment is at least thematically similar to E1-H5's recognition of a second TF program beyond YAP-TEAD (though AP-1 differs from MRTF-SRF).

**Divergences**: Different TF pairs (AP-1 vs MRTF-SRF). E1-H5 focuses on 3D chromatin architecture; holdout focuses on genomic identification and disease.

---

### C2-H7: H3K9me3 Demethylation Competence Windows -- Similarity: 3/10

**MAGELLAN's mechanism**: Force-induced H3K9me3 demethylation at nuclear interior enhancers creates competence windows for subsequent H3K27ac activation.

**Holdout mechanism**: Mechanoenhancers as ATAC-seq-defined regulatory elements.

**Shared concepts**: Both involve stiffness-driven enhancer accessibility changes.

**Divergences**: Completely different mechanisms. C2-H7 focuses on heterochromatin (H3K9me3) at nuclear interior; holdout uses ATAC-seq for accessibility profiling without addressing H3K9me3 or nuclear position.

---

## Verdict: CONTAMINATED

**Confidence**: MEDIUM

The session is formally CONTAMINATED because the holdout paper (Cosgrove et al. Science 2025) is explicitly referenced by DOI, PMID, full title, and author name in 4 session files. Per the holdout evaluation protocol, any reference to the holdout paper in session results yields a CONTAMINATED verdict regardless of mechanism similarity.

**Important nuance for interpretation**: The contamination is structurally limited to post-generation verification. All hypothesis generation occurred blind, and the final hypotheses (from cycle 2) were never exposed to the holdout paper. If evaluated on generation-phase output alone, the session would receive a PARTIAL_REDISCOVERY verdict at the lower boundary (best score 5/10). MAGELLAN independently converged on the correct general concept -- ECM stiffness regulates specific enhancer programs via the YAP-TEAD pathway, with different enhancer classes responding differently -- but did not identify mechanoenhancers as a distinct genomic class, did not propose genome-wide ATAC-seq or CRISPR screening as the discovery approach, and did not capture the IPF feed-forward disease mechanism. The pipeline proposed specific enzymatic mechanisms (HDAC3 depletion, UTX/COMPASS bivalent resolution, TET2 memory) that go beyond what the holdout paper addresses, representing complementary rather than overlapping mechanistic depth.

**Recommendation**: Re-run this holdout comparison with a session where the Quality Gate also runs in strict blind mode (no post-blind web verification step) to obtain a clean PARTIAL_REDISCOVERY determination. The generation-phase evidence strongly suggests the pipeline can independently arrive at the correct general territory (stiffness-to-enhancer regulation) through parametric knowledge alone.
